Binyou Wang

Ms. Binyou Wang

Southwest Medical University, Luzhou, Sichuan, China
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
BWBinyou Wang
Binyou Wang
XTXiaoqiu Tan
Xiaoqiu Tan
JGJianmin Guo
Jianmin Guo
TXTing Xiao
Ting Xiao
YJYan Jiao
Yan Jiao
YWYiwei Wang
Yiwei Wang
Drug-induced immune thrombocytopenia (DITP) often occurs in patients receiving many drug treatments simultaneously. However, clinicians usually fail to accurately distinguish which drugs can be plausible culprits. Despite significant advances in laboratory-based DITP testing, in vitro experimental assays have been expensive and, in certain cases, cannot provide a timely diagnosis to patients. To address these shortcomings, this paper proposes an efficient machine learning-based method for DITP toxicity prediction. A small dataset consisting of 225 molecules was constructed. The molecules were represented by six fingerprints, three descriptors, and their combinations. Seven classical machine learning-based models were examined to determine an optimal model. The results show that the RDMD + PubChem-k-NN model provides the best prediction performance among all the models, achieving an area under the curve of 76.9% and overall accuracy of 75.6% on the external validation set. The application domain (AD) analysis demonstrates the prediction reliability of the RDMD + PubChem-k-NN model. Five structural fragments related to the DITP toxicity are identified through information gain (IG) method along with fragment frequency analysis. Overall, as far as known, it is the first machine learning-based classification model for recognizing chemicals with DITP toxicity and can be used as an efficient tool in drug design and clinical therapy.

19 August 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
CJCongchao Jia
Congchao Jia
XPXianchao Pan
Xianchao Pan
BWBinyou Wang
Binyou Wang
PWPengyu Wang
Pengyu Wang
YWYiwei Wang
Yiwei Wang
RCRong Chen
Rong Chen
Background. Cisplatin is a frequently used and effective chemotherapy drug in clinical practice, but severe side effects limit its use, among which nephrotoxicity is considered the most serious and prolonged damage to the body. Astragalus membranaceus (AM) is a well-known herbal medicine, and modern pharmacological studies have confirmed its antioxidant, immunomodulatory, and antiapoptotic effects. Clinical studies have shown that AM and its active components can attenuate cisplatin-induced kidney damage, but the molecular mechanism has not been fully expounded. Materials and Methods. First, the components and targets information of AM were collected from the TCMSP, and the relevant targets of cisplatin-induced kidney damage were accessed from the GeneCards and OMIM databases. Then, the core targets were selected by the Venn diagram and network topology analysis, which was followed by GO and KEGG pathway enrichment analysis. Finally, we construct a component-target-pathway network. Furthermore, molecular docking was carried out to identify the binding activity between active components and key targets. Results. A total of 20 active components and 200 targets of AM and 646 targets related to cisplatin-induced kidney damage were obtained. 91 intersection targets were found between AM and cisplatin-induced kidney damage. Then, 16 core targets were identified, such as MAPK1, TNF-α, and p53. Furthermore, GO and KEGG pathway enrichment analysis suggested that MAPK, Toll-like receptor, and PI3K-Akt signaling pathways may be of significance in the treatment of cisplatin-induced kidney damage by AM. Molecular docking indicated that quercetin and kaempferol had high binding affinities with many core targets. Conclusion. In summary, the active components, key targets, and signaling pathways of AM in the treatment of cisplatin-induced kidney damage were predicted in this study, which contributed to the development and application of AM.

14 March 2025 in iScience
Verified
Journal Article
Open access
YWYiwei Wang
Yiwei Wang
BWBinyou Wang
Binyou Wang
JZJun Zou
Jun Zou
WAWu An-Guo
Wu An-Guo
YLYuan Liu
Yuan Liu
WJWu Jianming
Wu Jianming
Deep learning holds great promise in drug discovery, yet its application is hindered by high labeling costs and limited datasets. Developing algorithms that effectively learn from sparsely labeled data is crucial. Capsule networks (CapsNet), introduced in 2017, solve the spatial information loss in traditional neural networks and excel in handling small datasets by capturing spatial hierarchical relationships among features. This capability makes CapsNet particularly promising for drug discovery, where data scarcity is a common challenge. Various modified CapsNet architectures have been successfully applied to drug design and discovery tasks. This review provides a comprehensive analysis of CapsNet’s theoretical foundations, its current applications in drug discovery, and its performance in addressing key challenges in the field. Additionally, the study highlights the limitations of CapsNet and outlines potential future research directions to further enhance its utility in drug discovery, offering valuable insights for researchers in both computational and pharmaceutical sciences.

25 September 2025 in Psychiatry Investigation
Verified
Journal Article
Open access
PDF file
DSDan Shuai
Dan Shuai
BWBinyou Wang
Binyou Wang
DCDuanfang Cai
Duanfang Cai
YGYan Guo
Yan Guo
XLXiuping Lei
Xiuping Lei
YWYilin Wang
Yilin Wang
Objective To investigate the correlation between appendicular skeletal muscle mass (ASM)/height (ASMIht), ASM/body mass index (ASMIBMI), ASM/weight (ASMIwt), and ASM/waist circumference (ASMIwc) and cognitive function among inpatients with stable schizophrenia.Methods This was a cross-sectional study of 235 stable schizophrenia inpatients, including 60% males (n=141). Patient demographic information and body composition data were collected. The Montreal Cognitive Assessment-Chinese version (MoCA-C) was used to measure cognitive function. To determine the association between the muscle mass indices and cognitive function, multiple linear regressions were established.Results The median age of males and females were 51 years (range 42–55) and 51 (range 39–58), respectively. Spearman’s correlation analysis revealed a significant association between ASMIwc and the MoCA-C scores (r=0.323, false discovery rate [FDR]=0.004) in males, while ASMIBMI, ASMIwt, and ASMIwc (r=0.268–0.421, all FDR <0.05) were significantly correlated with MoCA-C scores in females. Furthermore, covariate-adjusted multiple linear regression analysis further confirmed that only the ASMIwc was related to MoCAC scores after controlling for relevant variables (males: β=0.565, 95% confidence interval [CI], 0.156–0.974, p=0.007; females: β=0.96, 95% CI, 0.394–1.526, p=0.001).Conclusion Our findings showed a substantial correlation between the ASMIwc and cognitive function in schizophrenia inpatients. Further validation of these data in broader study populations is now necessary.

8 October 2025 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
JHJian Han
Jian Han
XLXiu Li
Xiu Li
YFYanping Feng
Yanping Feng
YGYan Guo
Yan Guo
BWBinyou Wang
Binyou Wang
YWYilin Wang
Yilin Wang
The liver-brain axis, mediated by inflammatory cytokines, metabolic byproducts, and oxidative stress, shares pathological pathways with schizophrenia neurobiology. Despite this overlap, direct clinical evidence linking hepatic function indicators to psychiatric symptoms or cognitive function in schizophrenia remains limited. Therefore, this study investigated associations between clinical hepatic function indicators and both psychiatric symptoms and cognitive performance in individuals with stable schizophrenia. A cross-sectional study was conducted among 170 inpatients with clinically stable schizophrenia. Liver function indicators were obtained from fasting venous blood samples. Psychiatric symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS), and cognitive function was assessed with the Montreal Cognitive Assessment–Chinese version (MoCA-C). Multiple linear regression models, adjusted for covariates, were used to examine associations between hepatic indicators and outcomes (PANSS total/subscale scores; MoCA-C total score). After covariate adjustment, total bilirubin (TBil) (β = 0.29, 95% CI: 0.08–0.51; P = 0.008) and indirect bilirubin (IDBil) (β = 0.48, 95% CI: 0.17–0.80; P = 0.003) were significantly positively associated with MoCA-C scores. No significant associations were observed between any hepatic indicators and PANSS total/subscale scores. In this cross-sectional study of clinically stable schizophrenia, higher TBil and IDBil levels were associated with better cognitive performance. These findings suggest a potential role of bilirubin metabolism in cognitive function in schizophrenia, highlighting the need for further investigation into its relevance for cognitive impairment management.

15 May 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YFYanping Feng
Yanping Feng
YWYilin Wang
Yilin Wang
BWBinyou Wang
Binyou Wang
Objective: This exploratory study aims to investigate the relationship between handgrip strength (HGS) phenotypes and cortical hemodynamics in long-term hospitalized patients with stable schizophrenia, and to evaluate whether HGS could serve as a potential indicator of neurocognitive function in this population. Methods: In this cross-sectional study, 96 patients with stable schizophrenia were enrolled. HGS was assessed using a calibrated dynamometer. Cortical hemodynamic responses during a Verbal Fluency Task (VFT) were measured using functional near-infrared spectroscopy (fNIRS), with metrics derived from both oxygenated hemoglobin (Oxy-Hb) and total hemoglobin (Total-Hb) signals, including the S-integral, T-centroid, and K-activation. Statistical analyses comprised Spearman correlation analysis, univariate linear regression, and general linear models with post hoc comparisons. Results: Among the participants, 40.60% (39/96) were male and 59.40% (57/96) were female, with a median (P25, P75) age of 52 (42, 56) years. Univariate linear regression revealed a significant positive association between HGS asymmetry and frontal lobe S-integral values (Oxy-Hb: β = 65.650, 95% CI: 18.488–112.812, P = 0.007; Total-Hb: β = 64.878, 95% CI: 19.360–110.395, P = 0.006). However, after adjusting for potential confounders, general linear models revealed no significant differences in frontal S-integral values across HGS asymmetry subgroups, regardless of whether asymmetry was classified by percentage-based thresholds or dominance type (all Bonferroni-adjusted P > 0.05). Conclusion: In this exploratory study, HGS asymmetry was associated with frontal S-integral values unadjusted; however, after adjusting for confounders and multiple comparisons, no significant independent association remained. HGS phenotypes cannot be considered reliable or simple surrogate markers of neurocognitive activity in this population, underscoring the substantial influence of confounding neurophysiological factors in schizophrenia.